标题
Antiobesity Pharmacotherapy: New Drugs and Emerging Targets
作者
关键词
-
出版物
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 95, Issue 1, Pages 53-66
出版商
Springer Nature
发表日期
2013-10-08
DOI
10.1038/clpt.2013.204
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- New Obesity Agents: Lorcaserin and Phentermine/Topiramate
- (2013) Joshua W Fleming et al. ANNALS OF PHARMACOTHERAPY
- New advances in models and strategies for developing anti-obesity drugs
- (2013) Gilbert W Kim et al. Expert Opinion on Drug Discovery
- Increased cGMP promotes healthy expansion and browning of white adipose tissue
- (2013) Michaela M. Mitschke et al. FASEB JOURNAL
- Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonist
- (2012) Naoki Omori et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Serotonin Activates Overall Feeding by Activating Two Separate Neural Pathways in Caenorhabditis elegans
- (2012) B.-m. Song et al. JOURNAL OF NEUROSCIENCE
- Deciphering a neuronal circuit that mediates appetite
- (2012) Qi Wu et al. NATURE
- Unraveling the brain regulation of appetite: lessons from genetics
- (2012) Giles S H Yeo et al. NATURE NEUROSCIENCE
- Linaclotide approved for constipation-predominant IBS
- (2012) Katrina Ray Nature Reviews Gastroenterology & Hepatology
- Surgery or Medical Therapy for Obese Patients with Type 2 Diabetes?
- (2012) Paul Zimmet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study
- (2012) Patrick M. O'Neil et al. Obesity
- GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity
- (2012) Jieru Egeria Lin et al. PLoS One
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- From PDE3B to the regulation of energy homeostasis
- (2011) Eva Degerman et al. CURRENT OPINION IN PHARMACOLOGY
- Serotonergic Anti-Obesity Agents
- (2011) Jason C.G. Halford et al. DRUGS
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A uroguanylin-GUCY2C endocrine axis regulates feeding in mice
- (2011) Michael A. Valentino et al. JOURNAL OF CLINICAL INVESTIGATION
- Health and economic burden of the projected obesity trends in the USA and the UK
- (2011) Y Claire Wang et al. LANCET
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 Diabetes
- (2010) Olivia J. Phung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial
- (2010) Eric J Topol et al. LANCET
- Drug Management of Obesity — Efficacy versus Safety
- (2010) Arne Astrup NEW ENGLAND JOURNAL OF MEDICINE
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Meta-Analysis of Placebo-Controlled Clinical Trials Assessing the Efficacy and Safety of Incretin-Based Medications in Patients with Type 2 Diabetes
- (2010) Walid K.H. Fakhoury et al. PHARMACOLOGY
- New central targets for the treatment of obesity
- (2009) Bruce J. Sargent et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Endoplasmic Reticulum Stress Plays a Central Role in Development of Leptin Resistance
- (2009) Lale Ozcan et al. Cell Metabolism
- Potent and Selective Agonism of the Melanocortin Receptor 4 With MK-0493 Does Not Induce Weight Loss in Obese Human Subjects: Energy Intake Predicts Lack of Weight Loss Efficacy
- (2009) R Krishna et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Hormone Receptor GUCY2C Suppresses Intestinal Tumor Formation by Inhibiting AKT Signaling
- (2009) Jieru Egeria Lin et al. GASTROENTEROLOGY
- Uncoupling protein-1 (UCP1) contributes to the basal proton conductance of brown adipose tissue mitochondria
- (2009) Nadeene Parker et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Identification and Importance of Brown Adipose Tissue in Adult Humans
- (2009) Aaron M. Cypess et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy
- (2009) Eric Ravussin et al. Obesity
- AMPK and PPARδ Agonists Are Exercise Mimetics
- (2008) Vihang A. Narkar et al. CELL
- Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction
- (2008) Jarl E. S. Wikberg et al. NATURE REVIEWS DRUG DISCOVERY
- Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism?
- (2008) Martin C. Michel et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- 5-HT2CRs Expressed by Pro-Opiomelanocortin Neurons Regulate Energy Homeostasis
- (2008) Yong Xu et al. NEURON
- Rational Design of a Combination Medication for the Treatment of Obesity
- (2008) Frank L. Greenway et al. Obesity
- Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
- (2008) J. D. Roth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More